ScholarLens Back to search
2016•Endocrine AbstractsRequires access

The effect of peptide receptor radionuclide therapy (PRRT) on symptoms and tumour burden in patients with metastatic neuroendocrine tumour (NET)

Stalin Abraham, Ruth Casey, Ben Challis, Deborah Pitfield, Simon Whitley, Ashley Shaw, Sarah Heard, Zia Saad, John Buscombe, Helen Simpson

Open publisher page 0 citations

Abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

About this research paper

What this paper is about

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Key concepts: Radionuclide therapy, Peptide receptor, Neuroendocrine tumors, Medicine, Oncology, Internal medicine, Radionuclide, Peptide

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The effect of peptide receptor radionuclide therapy (PRRT) on symptoms and tumour burden in patients with metastatic neuroendocrine tumour (NET) — Research Paper | ScholarLens